CH610300A5 - - Google Patents

Info

Publication number
CH610300A5
CH610300A5 CH651874A CH651874A CH610300A5 CH 610300 A5 CH610300 A5 CH 610300A5 CH 651874 A CH651874 A CH 651874A CH 651874 A CH651874 A CH 651874A CH 610300 A5 CH610300 A5 CH 610300A5
Authority
CH
Switzerland
Application number
CH651874A
Inventor
Norman Allan Nelson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH610300A5 publication Critical patent/CH610300A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH651874A 1973-05-21 1974-05-13 CH610300A5 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/361,991 US3931279A (en) 1973-05-21 1973-05-21 5-Oxa prostaglandin F2.sub.α analogs

Publications (1)

Publication Number Publication Date
CH610300A5 true CH610300A5 (pl) 1979-04-12

Family

ID=23424252

Family Applications (1)

Application Number Title Priority Date Filing Date
CH651874A CH610300A5 (pl) 1973-05-21 1974-05-13

Country Status (13)

Country Link
US (1) US3931279A (pl)
JP (1) JPS5752326B2 (pl)
AU (1) AU476680B2 (pl)
BE (1) BE815355A (pl)
CH (1) CH610300A5 (pl)
DE (1) DE2423156A1 (pl)
DK (1) DK145083C (pl)
GB (1) GB1448414A (pl)
NL (1) NL7406556A (pl)
PL (1) PL97783B1 (pl)
SE (1) SE425485B (pl)
SU (1) SU620207A3 (pl)
ZA (1) ZA742574B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024179A (en) * 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
DE2524955C3 (de) * 1975-06-05 1981-12-03 Hoechst Ag, 6000 Frankfurt Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
US4054737A (en) * 1976-08-20 1977-10-18 The Upjohn Company Thromboxane B analogs
US4052552A (en) * 1976-08-20 1977-10-04 The Upjohn Company Thromboxane b analogs
US4107427A (en) * 1976-08-20 1978-08-15 The Upjohn Company Process and intermediates for preparing Thromboxane B1
US4228296A (en) * 1979-01-24 1980-10-14 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
WO1982002833A1 (en) * 1981-02-17 1982-09-02 Gail Sansone Bazzano The use of retinoids and their derivatives to increase the rate of growth of human scalp hair and to increase the rate of growth of fur in certain fur-bearing animals
DE3280344D1 (de) * 1981-11-09 1991-07-25 Gail S Bazzano Verwendung von retinoiden und minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxid) zur verbesserung des wachstums von menschlichem kopfhaar und zur behandlung bestimmter typen von alopecia.
IL143477A (en) * 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US7109371B2 (en) * 2004-01-05 2006-09-19 Johnson Matthey Public Limited Company Prostaglandin synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754114A (fr) * 1969-07-29 1971-01-29 Upjohn Co Nouveaux composes de la classe des prostaglandines et leur procede de preparation

Also Published As

Publication number Publication date
DK145083B (da) 1982-08-23
SE425485B (sv) 1982-10-04
JPS5752326B2 (pl) 1982-11-06
DE2423156A1 (de) 1974-12-12
SU620207A3 (ru) 1978-08-15
AU476680B2 (en) 1976-09-30
NL7406556A (pl) 1974-11-25
JPS5018441A (pl) 1975-02-26
GB1448414A (en) 1976-09-08
BE815355A (fr) 1974-11-21
ZA742574B (en) 1975-04-30
AU6839474A (en) 1975-10-30
US3931279A (en) 1976-01-06
DK145083C (da) 1983-01-24
PL97783B1 (pl) 1978-03-30

Similar Documents

Publication Publication Date Title
AR201758A1 (pl)
AU476761B2 (pl)
AU465372B2 (pl)
AR201235Q (pl)
AR201231Q (pl)
AU474593B2 (pl)
AU474511B2 (pl)
AU474838B2 (pl)
AU471343B2 (pl)
AU465453B2 (pl)
AU465434B2 (pl)
AU450229B2 (pl)
AU476714B2 (pl)
AR201229Q (pl)
AU466283B2 (pl)
AU476696B2 (pl)
AU472848B2 (pl)
AR199451A1 (pl)
AU477823B2 (pl)
AR200885A1 (pl)
AR197627A1 (pl)
AR210729A1 (pl)
AR200256A1 (pl)
AR195311A1 (pl)
AU461342B2 (pl)

Legal Events

Date Code Title Description
PL Patent ceased